First-Ever OTC Inspections Drove Surge Of FDA Warning Letters In FY 2019

 
• By Joanne S. Eglovitch

The good news: 75% of never-before-inspected firms complied with US drug GMP requirements. The bad news: 25% did not.

Warning Rubber Stamp
FDA Investigators Focused On Uninspected Inventory In FY 2019 • Source: Shutterstock

More from Manufacturing

More from Compliance